Biologic reaction in interface tissue of aseptic loosening THA.

无菌松动THA界面组织的生物反应。

基本信息

  • 批准号:
    07457330
  • 负责人:
  • 金额:
    $ 2.75万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

It had been clearly demonstrated that matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMPs) had important roles for tissue destruction and remodeling. we used the reverse-transcriptinal polymerase chain reaction (RT-PCR) for this study. We could detect the mRNA of MMP-1,2,3,9 and TIMP-1,2 in interface tissue. The mRNA of MMP-10 could not be detected. MMP-1 and MMP-3mRNA were observed commonly. TIMP-2mRNA were well observed, compared to TIMP-1. These observations may indicated all four enzymes cooperatively caused the undesirable bone loss around implants, and consequently resulted in failed THA.We considered that the MMPs and TIMPs play one of the critical roles for the progression of aseptic loosening of THA.Also the roles of macrophages was assessed by immunohistochemistry, electron microscopy, and molecular biological techniques. After extraction of total RNA,we used the RT-PCR to examine the expression of mRNA for IL-1a, IL-1b, TNFa, IL-8, MIP-1a, MIP-1b and MCP-1. Polyethylene debris surrounded by macrophages and phagocytosis of debris by macrophages were frequently observed in the interface tissue. Expression of chemokine mRNAs was also commonly seen, suggesting that this led to recruitment of macrophages into the bone-cement interface tissue. Macrophage activation and the production of inflammatory cytokines like IL-1 and IL-8 might induce the development of interface tissue. Debris released from implants appear to causes activation of macrophages and the production of inflammatory cytokines that induce cellular recruitment into interface tissue. This mechanism might form a vicious cycle that aggravates THA loosening.
基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)在组织破坏和重塑中起重要作用。本研究采用逆转录聚合酶链反应(RT-PCR)技术。MMP-1、2、3、9和TIMP-1、2在界面组织中的mRNA表达。MMP-10 mRNA表达阴性。MMP-1和MMP-3 mRNA在乳腺癌组织中普遍表达。TIMP-2 mRNA表达较TIMP-1明显增强。我们认为MMPs和TIMPs在THA无菌性松动的发生发展过程中起着重要作用,并通过免疫组化、电镜和分子生物学技术对巨噬细胞的作用进行了研究。提取总RNA后,采用RT-PCR检测IL-1a、IL-1b、TNF α、IL-8、MIP-1a、MIP-1b和MCP-1 mRNA的表达。在界面组织中经常观察到巨噬细胞包围聚乙烯碎片和巨噬细胞吞噬碎片。还常见趋化因子mRNA的表达,表明这导致巨噬细胞募集到骨-骨水泥界面组织中。巨噬细胞的活化和炎性细胞因子如IL-1和IL-8的产生可能诱导界面组织的发育。从植入物释放的碎片似乎会导致巨噬细胞活化和炎症细胞因子的产生,从而诱导细胞募集到界面组织中。这种机制可能形成一个恶性循环,导致THA松动。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Naoki Ishiguro et al.: "Determination of Stromelysin-1(MMP-3), 72kDa and 92kDa Gelatinase (MMP-2,9), Tissue Inhibitor of Metalloproteinases-1(TIMP-1), and TIMP-2 in Synovial Fluid and Serum from Patients with Rheumatoid Arthritis." Journal of Rheumatology
Naoki Ishiguro 等人:“滑液和组织液中 Stromelysin-1 (MMP-3)、72kDa 和 92kDa 明胶酶 (MMP-2,9)、金属蛋白酶组织抑制剂 (TIMP-1) 和 TIMP-2 的测定
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yuichiro Yabe, Naoki Ishiguro et al.: "A perfluorochemical prevents ischemia-reperfusion injury of muscle." Journal of Surgical Research. 64. 89-94 (1996)
Yuichiro Yabe、Naoki Ishiguro 等人:“全氟化合物可预防肌肉缺血再灌注损伤。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Naoki Ishiguro et al.: "mRNA expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase in the interace tissue around implants in loosening total hip arthorplasty." Jouranal of Biomedical Matarial Research. 32. 611-617 (1996)
Naoki Ishiguro 等人:“松解全髋关节置换术中植入物周围的界面组织中基质金属蛋白酶和金属蛋白酶组织抑制剂的 mRNA 表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Naoki Ishiguro et al.: "Macrophage activation and migration in interface tissue around of loosening total hip arthropathy components." Journal of Biomedical Material Research. (in press).
Naoki Ishiguro 等人:“松动的全髋关节病成分周围的界面组织中的巨噬细胞激活和迁移。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISHIGURO Naoki其他文献

ISHIGURO Naoki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISHIGURO Naoki', 18)}}的其他基金

Development of a new therapeutic drug for osteoarthritis that has a cartilage-protecting effect by inhibiting Wnt/ADAM10
开发通过抑制Wnt/ADAM10具有软骨保护作用的骨关节炎新治疗药物
  • 批准号:
    19H03779
  • 财政年份:
    2019
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
TRPV4, a Ca ion channel plays pivotal role in chondrogenic mechanotransduction in ATDC5
TRPV4,一种 Ca 离子通道,在 ATDC5 的软骨形成机械转导中发挥关键作用
  • 批准号:
    24659671
  • 财政年份:
    2012
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The research of the drugs that can promote SOX9m RNA expression in chondrocyte
促进软骨细胞SOX9m RNA表达的药物研究
  • 批准号:
    22659269
  • 财政年份:
    2010
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The Research of the bioreactor that can promote the cell differentiation from bone marrow stem cells to osteogenic cells
促进骨髓干细胞向成骨细胞分化的生物反应器的研究
  • 批准号:
    21390419
  • 财政年份:
    2009
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The development of tissue engineering procedure for osteogensesis -investigation using plate rich plasma and mesenchymal stem cell-
成骨组织工程程序的开发 - 使用富含平板的血浆和间充质干细胞进行研究 -
  • 批准号:
    17390416
  • 财政年份:
    2005
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The application of osteoblast-like cells and platelet rich plasma gels transplantation for accelerating the bone regeneration in the distraction osteogenesis.
成骨细胞样细胞和富血小板血浆凝胶移植在牵引成骨中加速骨再生的应用。
  • 批准号:
    14370461
  • 财政年份:
    2002
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The effects of degenerative products from matrix on syanovial cells and chondrocytes metabolism
基质变性产物对滑膜细胞和软骨细胞代谢的影响
  • 批准号:
    09470312
  • 财政年份:
    1997
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

基于“肝主泪”和Cytokines/P38MAPK/P53炎症相关通路的养阴润目丸治疗干眼的研究
  • 批准号:
    81674030
  • 批准年份:
    2016
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
基于“功能药对分析模式”研究逍遥散抗抑郁作用的BDNF/HPA/cytokines靶位整合调节机制
  • 批准号:
    81503277
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
  • 批准号:
    10495114
  • 财政年份:
    2023
  • 资助金额:
    $ 2.75万
  • 项目类别:
Tyk2 and Associated Cytokines in Salivary Gland Autoimmunity
Tyk2 和唾液腺自身免疫中的相关细胞因子
  • 批准号:
    10733367
  • 财政年份:
    2023
  • 资助金额:
    $ 2.75万
  • 项目类别:
Deciphering macrophage phenotypes in neuropathic pain
破译神经性疼痛中的巨噬细胞表型
  • 批准号:
    461574
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Operating Grants
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
针对细胞因子/趋化因子的异常表达来治疗炎症性肾炎
  • 批准号:
    10525534
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
针对细胞因子/趋化因子的异常表达来治疗炎症性肾炎
  • 批准号:
    10651843
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
Tankyrase represses macrophage derived inflammatory cytokines and controls osteoclast activity during bone development.
端锚聚合酶抑制巨噬细胞衍生的炎症细胞因子并控制骨骼发育过程中的破骨细胞活性。
  • 批准号:
    469104
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Operating Grants
Multi-target suppression of pro-inflammatory cytokines using engineered targeted ribonucleases
使用工程化靶向核糖核酸酶多靶点抑制促炎细胞因子
  • 批准号:
    10282169
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines
通过调节骨髓细胞因子实现更安全、更有效的 CART 细胞疗法
  • 批准号:
    10538587
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines
通过调节骨髓细胞因子实现更安全、更有效的 CART 细胞疗法
  • 批准号:
    10340529
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
The Role of Obesity on Alphavirus Disease Severity
肥胖对甲病毒病严重程度的影响
  • 批准号:
    10303398
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了